BTCS Inc
BTCS
Bakkt Holdings
BKKT
Bitdeer Technologies
BTDR
4
CleanSpark
CLSK
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
RVPH Reviva Pharmaceuticals
- 0.7824
- +0.0734+10.35%
Close Apr 17 16:00 ET
- 0.7577
- -0.0247-3.16%
Post 20:01 ET
36.57MMarket Cap-0.87P/E (TTM)
0.8000High0.6958Low323.02KVolume0.6969Open0.7090Pre Close249.26KTurnover0.79%Turnover RatioLossP/E (Static)46.74MShares4.280052wk High46.02P/B31.90MFloat Cap0.485052wk Low--Dividend TTM40.78MShs Float15.1000Historical High--Div YieldTTM14.70%Amplitude0.4850Historical Low0.7710Avg Price1Lot Size
Reviva Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.43%-33.54M | -2.52%-9.1M | 31.36%-4.24M | -59.41%-8.48M | -47.47%-11.73M | -49.39%-28.32M | -89.24%-8.88M | -54.41%-6.18M | -32.89%-5.32M | -26.88%-7.95M |
| Net income from continuing operations | 23.79%-29.92M | 33.09%-6.26M | 26.27%-8.37M | 32.87%-7.86M | -8.49%-7.43M | -38.92%-39.26M | 22.30%-9.36M | -222.76%-11.35M | -119.22%-11.71M | 6.97%-6.85M |
| Operating gains losses | -400.00%-717.65K | 116.67%11.13K | 48.00%-72.32K | -143.90%-200.27K | -4,000.10%-456.18K | 22.86%239.22K | -114.46%-66.76K | ---139.08K | 356.25%456.18K | 87.50%-11.13K |
| Depreciation and amortization | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 |
| Change In working capital | -162.30%-4.54M | -2,297.98%-3.41M | -22.33%3.85M | -123.39%-774.99K | -268.83%-4.21M | -18.43%7.28M | -97.73%154.98K | 1,039.80%4.96M | 124.25%3.31M | -199.35%-1.14M |
| -Change in prepaid assets | -2,489.47%-1.69M | -45.85%44.3K | -171.30%-196.56K | -136.79%-351.51K | 4.19%-1.19M | -94.60%70.89K | -65.58%81.81K | -33.18%275.7K | 73.18%955.53K | -1,227.05%-1.24M |
| -Change in payables and accrued expense | -139.43%-2.84M | -4,816.21%-3.45M | -13.56%4.05M | -117.96%-423.48K | -3,054.68%-3.02M | -5.31%7.21M | -98.89%73.17K | 597.89%4.68M | 154.69%2.36M | -90.16%102.04K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.43%-33.54M | -2.52%-9.1M | 31.36%-4.24M | -59.41%-8.48M | -47.47%-11.73M | -49.39%-28.32M | -89.24%-8.88M | -54.41%-6.18M | -32.89%-5.32M | -26.88%-7.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -28.70%23.65M | -37.60%17.02M | 3.62M | -48.58%2.68M | -51.68%332K | 325.69%33.17M | 146,813.77%27.27M | 0 | 5.21M | 981,461.43%687.09K |
| Net issuance payments of debt | --458.15K | 268.61%375.15K | ---124.5K | 72.02%-124.5K | -50.26%332K | --0 | ---222.5K | --0 | ---445K | --667.5K |
| Net common stock issuance | -15.64%23.19M | -39.47%16.64M | --3.75M | ---- | ---- | 253.69%27.49M | --27.49M | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | -100.00%149 | --114 | --35 | --0 | --0 | 29,836.99%5.68M | --0 | --0 | --5.66M | 27,890.00%19.59K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -28.70%23.65M | -37.60%17.02M | --3.62M | -48.58%2.68M | -51.68%332K | 325.69%33.17M | 146,813.77%27.27M | --0 | --5.21M | 981,461.43%687.09K |
| Net cash flow | ||||||||||
| Beginning cash position | 26.18%23.37M | 11.80%5.56M | -44.60%6.18M | 6.38%11.97M | 26.18%23.37M | -37.62%18.52M | -78.56%4.97M | -42.58%11.15M | -51.94%11.26M | -37.62%18.52M |
| Current changes in cash | -304.04%-9.89M | -56.96%7.92M | 89.98%-619.36K | -5,474.17%-5.8M | -56.85%-11.39M | 143.41%4.85M | 493.73%18.4M | -263.83%-6.18M | 97.40%-103.97K | -15.92%-7.26M |
| End cash Position | -42.33%13.48M | -42.33%13.48M | 11.80%5.56M | -44.60%6.18M | 6.38%11.97M | 26.18%23.37M | 26.18%23.37M | -78.56%4.97M | -42.58%11.15M | -51.94%11.26M |
| Free cash flow | -18.43%-33.54M | -2.52%-9.1M | 31.36%-4.24M | -59.41%-8.48M | -47.47%-11.73M | -49.39%-28.32M | -89.24%-8.88M | -54.41%-6.18M | -32.89%-5.32M | -26.88%-7.95M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call